All In Biotech

Drug Trial Radar · NCT00403104

Placebo Controlled Study of ONO2506PO in the Presence of Riluzole in Patients With Amyotrophic Lateral Sclerosis (ALS)

A Multi-centre, Randomized, Double Blind, Placebo-controlled, Parallel Group Study to Investigate Efficacy and Safety of ONO-2506PO Compared to Placebo, in the Presence of Riluzole, to Patients Diagnosed With Amyotrophic Lateral Sclerosis (ALS), Who Have Had Onset of Muscle Weakness Within 14 Months of Randomization

Last checked: Nov 20, 2026Latest source record: Jun 13, 2012 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 420 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

420

Actual

Start

Nov 2006

Primary completion

Dec 2008

Study completion Dec 2008

Sponsor

Lead sponsor
Ono Pharmaceutical Co., Ltd.Industry
Sponsor type
Industry
First posted
Nov 23, 2006

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 74 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to determine if oral treatment with ONO-2506PO in patients diagnosed with ALS, who have had onset of muscle weakness within 14 months of randomization, could lead to the slowing of decline in respiratory function, functional status, muscle strength, quality of life and survival compared with placebo group.

Conditions

  • Amyotrophic Lateral Sclerosis (ALS)

Interventions

  • ONO-2506PODrug

    1200 mg QD / 18 months

  • ONO-2506PODrug

    0 mg QD / 18 months

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Rate of decline of respiratory function determined as SVC over the 12 month treatment periodTime frame: 12 months

Locations

26 sites in 8 countries. Site status is shown where the registry gives one.

  • L. Boltzmann Forschungsinstitut, Neurologische Abteilung, Kaiser Franz Josef Hospital, Wien

    Vienna, Austria

  • UCL Saint-Luc

    Brussels, Belgium

  • UZ Leuven

    Leuven, Belgium

  • Hopital Roger Salengro - Clinique Neurologique, Neurologie A

    Lille, France

  • Hopital Duruytren

    Limoges, France

  • Hopital de la Timone

    Marseille, France

  • Hopital de Chauliac

    Montpellier, France

  • Hopital l-Archet 1

    Nice, France

  • Hopital LaPitie Salpetriere

    Paris, France

  • Charite Campus Virchow, ALS Ambulanz

    Berlin, Germany

  • Neurologische Universitatsklinik Bergmannsheil

    Bochum, Germany

  • Poliklinik der Universitat Erlangen-Nurnberg, Neurologische Klinik

    Erlangen, Germany

  • Martin-Luther-Universitat Halle-Wittenberg, Klinikum der Medizinischen Fakultat, Universitatsklinik und Poliklinik fur Neurologie

    Halle, Germany

  • Medizinische Hochschule Hannover, Neurologische Klinik

    Hanover, Germany

  • Interdisziplinares Zentrum fur Palliativmedizin

    München, Germany

  • Klinik und Poliklinik fur Neurologie der Universitat Ulm-Universitatsklinikum Ulm

    Ulm, Germany

  • Deutsche Klinik fur Diagnostik, Fachbereich Neurologie

    Wiesbaden, Germany

  • Dipartimento di Neurologia e Laboratorio di Neuroscienze - Universita di Milano - IRCCS - Istituto Auxologico Italiano

    Milan, Italy

  • Divisione di Neuroriabilitazione II - Fondazione Salvatore Maugeri - IRCCS

    Pavia, Italy

  • Dipartimento di Neuroscienze - Divisione di Neurologia II - Azienda Ospedaliera S. Giovanni Battista - Molinette

    Torino, Italy

  • Academic Medical Centre (AMC) Amsterdam - Dept of Neurology

    Amsterdam, Netherlands

  • University Medial Center Utrecht

    Utrecht, Netherlands

  • Kantonsspital St. Gallen, Muskelzentrum/ALS Clinic

    Sankt Gallen, Switzerland

  • Academic Neuroscience Centre

    London, United Kingdom

  • Royal Preston Hospital

    Preston, United Kingdom

  • University of Sheffield - Academic Neurology Unit

    Sheffield, United Kingdom

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.